Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide
['Bone regeneration', 'Bone scaffold', 'Ectopic bone formation', 'Growth factor', 'Targeting system']
